BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37895104)

  • 1. Human Non-Small Cell Lung Cancer-Chicken Embryo Chorioallantoic Membrane Tumor Models for Experimental Cancer Treatments.
    Li J; Brachtlova T; van der Meulen-Muileman IH; Kleerebezem S; Liu C; Li P; van Beusechem VW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.
    Huang WT; Cen WL; He RQ; Xie Y; Zhang Y; Li P; Gan TQ; Chen G; Hu XH
    Mol Med Rep; 2017 Dec; 16(6):8781-8792. PubMed ID: 28990079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumors derived from lung cancer cells respond differently to treatment with sodium valproate (a HDAC inhibitor) in a chicken embryo chorioallantoic membrane model.
    Diržiuvienė R; Šlekienė L; Palubinskienė J; Balnytė I; Lasienė K; Stakišaitis D; Valančiūtė A
    Histol Histopathol; 2022 Dec; 37(12):1201-1212. PubMed ID: 35703146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo.
    Duan Z; Deng J; Dong Y; Zhu C; Li W; Fan D
    Food Funct; 2017 Oct; 8(10):3723-3736. PubMed ID: 28949353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
    Cheng R; Lu C; Zhang G; Zhang G; Zhao G
    Oncol Rep; 2017 Apr; 37(4):2129-2136. PubMed ID: 28350100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC.
    La Monica S; Minari R; Cretella D; Flammini L; Fumarola C; Bonelli M; Cavazzoni A; Digiacomo G; Galetti M; Madeddu D; Falco A; Lagrasta CA; Squadrilli A; Barocelli E; Romanel A; Quaini F; Petronini PG; Tiseo M; Alfieri R
    J Exp Clin Cancer Res; 2019 May; 38(1):222. PubMed ID: 31138260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.
    Li M; Pathak RR; Lopez-Rivera E; Friedman SL; Aguirre-Ghiso JA; Sikora AG
    J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorin e6 - polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts.
    Chin WW; Heng PW; Olivo M
    BMC Pharmacol; 2007 Dec; 7():15. PubMed ID: 18053148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the chicken embryo chorioallantoic membrane assay to study treatment approaches in urothelial carcinoma.
    Skowron MA; Sathe A; Romano A; Hoffmann MJ; Schulz WA; van Koeveringe GA; Albers P; Nawroth R; Niegisch G
    Urol Oncol; 2017 Sep; 35(9):544.e11-544.e23. PubMed ID: 28551413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
    Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
    Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
    Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
    PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer to chicks using lentiviral vectors administered via the embryonic chorioallantoic membrane.
    Hen G; Yosefi S; Shinder D; Or A; Mygdal S; Condiotti R; Galun E; Bor A; Sela-Donenfeld D; Friedman-Einat M
    PLoS One; 2012; 7(5):e36531. PubMed ID: 22606269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [hVEGF siRNA inhibits initial growth of A549 tumor cells in nude mice and angiogenesis on CAM assay].
    Liu R; Ma WJ; Zhou JY; Yang GD; Zhou JY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 38(2):136-44. PubMed ID: 19363820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma.
    Kunz P; Schenker A; Sähr H; Lehner B; Fellenberg J
    PLoS One; 2019; 14(4):e0215312. PubMed ID: 30986223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer.
    Muhammad T; Sakhawat A; Khan AA; Huang H; Khan HR; Huang Y; Wang J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):861-874. PubMed ID: 32088783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.
    He RQ; Li XJ; Liang L; Xie Y; Luo DZ; Ma J; Peng ZG; Hu XH; Chen G
    BMC Cancer; 2017 Sep; 17(1):655. PubMed ID: 28927388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer.
    Feng L; Yao HP; Zhou YQ; Zhou J; Zhang R; Wang MH
    J Exp Clin Cancer Res; 2016 Apr; 35():70. PubMed ID: 27102688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
    Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
    Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing.
    Rovithi M; Avan A; Funel N; Leon LG; Gomez VE; Wurdinger T; Griffioen AW; Verheul HM; Giovannetti E
    Sci Rep; 2017 Mar; 7():44686. PubMed ID: 28304379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.